nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ORM1—Vemurafenib—melanoma	0.312	0.7	CbGbCtD
Doxazosin—ABCB1—melanoma	0.246	1	CbGaD
Doxazosin—CYP2D6—Vemurafenib—melanoma	0.0648	0.145	CbGbCtD
Doxazosin—ABCB1—Dactinomycin—melanoma	0.0457	0.102	CbGbCtD
Doxazosin—ABCB1—Docetaxel—melanoma	0.0236	0.0528	CbGbCtD
Doxazosin—Hypersensitivity—Vemurafenib—melanoma	0.000484	0.00221	CcSEcCtD
Doxazosin—Menopausal symptoms—Docetaxel—melanoma	0.000481	0.0022	CcSEcCtD
Doxazosin—Atrial fibrillation—Docetaxel—melanoma	0.000479	0.00219	CcSEcCtD
Doxazosin—Hepatitis—Temozolomide—melanoma	0.000472	0.00216	CcSEcCtD
Doxazosin—Asthenia—Vemurafenib—melanoma	0.000471	0.00215	CcSEcCtD
Doxazosin—Visual impairment—Carmustine—melanoma	0.000471	0.00215	CcSEcCtD
Doxazosin—Hypoaesthesia—Temozolomide—melanoma	0.00047	0.00215	CcSEcCtD
Doxazosin—Pharyngitis—Temozolomide—melanoma	0.000469	0.00214	CcSEcCtD
Doxazosin—Chills—Dactinomycin—melanoma	0.000469	0.00214	CcSEcCtD
Doxazosin—Cardiac failure—Docetaxel—melanoma	0.000465	0.00213	CcSEcCtD
Doxazosin—Pruritus—Vemurafenib—melanoma	0.000465	0.00212	CcSEcCtD
Doxazosin—Alopecia—Dactinomycin—melanoma	0.000461	0.00211	CcSEcCtD
Doxazosin—Eye disorder—Carmustine—melanoma	0.000457	0.00209	CcSEcCtD
Doxazosin—Visual impairment—Temozolomide—melanoma	0.000455	0.00208	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000454	0.00207	CcSEcCtD
Doxazosin—Flushing—Carmustine—melanoma	0.000454	0.00207	CcSEcCtD
Doxazosin—Ill-defined disorder—Bleomycin—melanoma	0.000452	0.00207	CcSEcCtD
Doxazosin—Diarrhoea—Vemurafenib—melanoma	0.000449	0.00205	CcSEcCtD
Doxazosin—Migraine—Docetaxel—melanoma	0.000447	0.00204	CcSEcCtD
Doxazosin—Eye disorder—Temozolomide—melanoma	0.000441	0.00202	CcSEcCtD
Doxazosin—Tinnitus—Temozolomide—melanoma	0.00044	0.00201	CcSEcCtD
Doxazosin—Malaise—Bleomycin—melanoma	0.00044	0.00201	CcSEcCtD
Doxazosin—Flushing—Temozolomide—melanoma	0.000438	0.002	CcSEcCtD
Doxazosin—Arrhythmia—Carmustine—melanoma	0.000437	0.00199	CcSEcCtD
Doxazosin—Leukopenia—Bleomycin—melanoma	0.000436	0.00199	CcSEcCtD
Doxazosin—Dizziness—Vemurafenib—melanoma	0.000434	0.00198	CcSEcCtD
Doxazosin—Alopecia—Carmustine—melanoma	0.000432	0.00197	CcSEcCtD
Doxazosin—Mental disorder—Carmustine—melanoma	0.000428	0.00196	CcSEcCtD
Doxazosin—Ataxia—Docetaxel—melanoma	0.000427	0.00195	CcSEcCtD
Doxazosin—Malnutrition—Carmustine—melanoma	0.000425	0.00194	CcSEcCtD
Doxazosin—Cough—Bleomycin—melanoma	0.000425	0.00194	CcSEcCtD
Doxazosin—Chills—Temozolomide—melanoma	0.000424	0.00194	CcSEcCtD
Doxazosin—Dehydration—Docetaxel—melanoma	0.000422	0.00193	CcSEcCtD
Doxazosin—Ill-defined disorder—Dactinomycin—melanoma	0.000422	0.00193	CcSEcCtD
Doxazosin—Liver function test abnormal—Docetaxel—melanoma	0.000419	0.00191	CcSEcCtD
Doxazosin—Vomiting—Vemurafenib—melanoma	0.000417	0.00191	CcSEcCtD
Doxazosin—Alopecia—Temozolomide—melanoma	0.000417	0.00191	CcSEcCtD
Doxazosin—Dry skin—Docetaxel—melanoma	0.000416	0.0019	CcSEcCtD
Doxazosin—Chest pain—Bleomycin—melanoma	0.000415	0.0019	CcSEcCtD
Doxazosin—Myalgia—Bleomycin—melanoma	0.000415	0.0019	CcSEcCtD
Doxazosin—Orthostatic hypotension—Docetaxel—melanoma	0.000415	0.00189	CcSEcCtD
Doxazosin—Rash—Vemurafenib—melanoma	0.000414	0.00189	CcSEcCtD
Doxazosin—Mental disorder—Temozolomide—melanoma	0.000414	0.00189	CcSEcCtD
Doxazosin—Dermatitis—Vemurafenib—melanoma	0.000414	0.00189	CcSEcCtD
Doxazosin—Back pain—Carmustine—melanoma	0.000412	0.00188	CcSEcCtD
Doxazosin—Headache—Vemurafenib—melanoma	0.000411	0.00188	CcSEcCtD
Doxazosin—Malnutrition—Temozolomide—melanoma	0.000411	0.00188	CcSEcCtD
Doxazosin—Discomfort—Bleomycin—melanoma	0.00041	0.00187	CcSEcCtD
Doxazosin—Malaise—Dactinomycin—melanoma	0.00041	0.00187	CcSEcCtD
Doxazosin—Cramp muscle—Docetaxel—melanoma	0.000409	0.00187	CcSEcCtD
Doxazosin—Leukopenia—Dactinomycin—melanoma	0.000407	0.00186	CcSEcCtD
Doxazosin—Dysgeusia—Temozolomide—melanoma	0.000403	0.00184	CcSEcCtD
Doxazosin—Confusional state—Bleomycin—melanoma	0.000401	0.00183	CcSEcCtD
Doxazosin—Vision blurred—Carmustine—melanoma	0.000401	0.00183	CcSEcCtD
Doxazosin—Tremor—Carmustine—melanoma	0.000399	0.00182	CcSEcCtD
Doxazosin—Oedema—Bleomycin—melanoma	0.000398	0.00182	CcSEcCtD
Doxazosin—Back pain—Temozolomide—melanoma	0.000398	0.00182	CcSEcCtD
Doxazosin—Infection—Bleomycin—melanoma	0.000395	0.00181	CcSEcCtD
Doxazosin—Agitation—Carmustine—melanoma	0.000391	0.00179	CcSEcCtD
Doxazosin—Nausea—Vemurafenib—melanoma	0.00039	0.00178	CcSEcCtD
Doxazosin—Thrombocytopenia—Bleomycin—melanoma	0.000389	0.00178	CcSEcCtD
Doxazosin—Vision blurred—Temozolomide—melanoma	0.000387	0.00177	CcSEcCtD
Doxazosin—Myalgia—Dactinomycin—melanoma	0.000387	0.00177	CcSEcCtD
Doxazosin—Bronchospasm—Docetaxel—melanoma	0.000386	0.00176	CcSEcCtD
Doxazosin—Tremor—Temozolomide—melanoma	0.000385	0.00176	CcSEcCtD
Doxazosin—Discomfort—Dactinomycin—melanoma	0.000382	0.00175	CcSEcCtD
Doxazosin—Angina pectoris—Docetaxel—melanoma	0.000382	0.00175	CcSEcCtD
Doxazosin—Ill-defined disorder—Temozolomide—melanoma	0.000381	0.00174	CcSEcCtD
Doxazosin—Leukopenia—Carmustine—melanoma	0.000381	0.00174	CcSEcCtD
Doxazosin—Anorexia—Bleomycin—melanoma	0.000379	0.00173	CcSEcCtD
Doxazosin—Agitation—Temozolomide—melanoma	0.000378	0.00173	CcSEcCtD
Doxazosin—Hypotension—Bleomycin—melanoma	0.000372	0.0017	CcSEcCtD
Doxazosin—Oedema—Dactinomycin—melanoma	0.000371	0.00169	CcSEcCtD
Doxazosin—Malaise—Temozolomide—melanoma	0.000371	0.00169	CcSEcCtD
Doxazosin—Vertigo—Temozolomide—melanoma	0.000369	0.00169	CcSEcCtD
Doxazosin—Convulsion—Carmustine—melanoma	0.000369	0.00168	CcSEcCtD
Doxazosin—Infection—Dactinomycin—melanoma	0.000369	0.00168	CcSEcCtD
Doxazosin—Leukopenia—Temozolomide—melanoma	0.000368	0.00168	CcSEcCtD
Doxazosin—Hypertension—Carmustine—melanoma	0.000367	0.00168	CcSEcCtD
Doxazosin—Neutropenia—Docetaxel—melanoma	0.000367	0.00168	CcSEcCtD
Doxazosin—Palpitations—Temozolomide—melanoma	0.000363	0.00166	CcSEcCtD
Doxazosin—Thrombocytopenia—Dactinomycin—melanoma	0.000363	0.00166	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000362	0.00166	CcSEcCtD
Doxazosin—Myalgia—Carmustine—melanoma	0.000362	0.00165	CcSEcCtD
Doxazosin—Chest pain—Carmustine—melanoma	0.000362	0.00165	CcSEcCtD
Doxazosin—Anxiety—Carmustine—melanoma	0.000361	0.00165	CcSEcCtD
Doxazosin—Cough—Temozolomide—melanoma	0.000359	0.00164	CcSEcCtD
Doxazosin—Paraesthesia—Bleomycin—melanoma	0.000357	0.00163	CcSEcCtD
Doxazosin—Weight increased—Docetaxel—melanoma	0.000357	0.00163	CcSEcCtD
Doxazosin—Convulsion—Temozolomide—melanoma	0.000356	0.00163	CcSEcCtD
Doxazosin—Weight decreased—Docetaxel—melanoma	0.000355	0.00162	CcSEcCtD
Doxazosin—Hypertension—Temozolomide—melanoma	0.000355	0.00162	CcSEcCtD
Doxazosin—Dyspnoea—Bleomycin—melanoma	0.000355	0.00162	CcSEcCtD
Doxazosin—Anorexia—Dactinomycin—melanoma	0.000354	0.00162	CcSEcCtD
Doxazosin—Pneumonia—Docetaxel—melanoma	0.000352	0.00161	CcSEcCtD
Doxazosin—Confusional state—Carmustine—melanoma	0.00035	0.0016	CcSEcCtD
Doxazosin—Arthralgia—Temozolomide—melanoma	0.00035	0.0016	CcSEcCtD
Doxazosin—Myalgia—Temozolomide—melanoma	0.00035	0.0016	CcSEcCtD
Doxazosin—Anxiety—Temozolomide—melanoma	0.000349	0.00159	CcSEcCtD
Doxazosin—Oedema—Carmustine—melanoma	0.000347	0.00159	CcSEcCtD
Doxazosin—Discomfort—Temozolomide—melanoma	0.000346	0.00158	CcSEcCtD
Doxazosin—Decreased appetite—Bleomycin—melanoma	0.000346	0.00158	CcSEcCtD
Doxazosin—Infection—Carmustine—melanoma	0.000345	0.00158	CcSEcCtD
Doxazosin—Acute coronary syndrome—Docetaxel—melanoma	0.000345	0.00158	CcSEcCtD
Doxazosin—Myocardial infarction—Docetaxel—melanoma	0.000343	0.00157	CcSEcCtD
Doxazosin—Dry mouth—Temozolomide—melanoma	0.000342	0.00156	CcSEcCtD
Doxazosin—Jaundice—Docetaxel—melanoma	0.000341	0.00156	CcSEcCtD
Doxazosin—Pain—Bleomycin—melanoma	0.00034	0.00155	CcSEcCtD
Doxazosin—Conjunctivitis—Docetaxel—melanoma	0.00034	0.00155	CcSEcCtD
Doxazosin—Thrombocytopenia—Carmustine—melanoma	0.00034	0.00155	CcSEcCtD
Doxazosin—Tachycardia—Carmustine—melanoma	0.000339	0.00155	CcSEcCtD
Doxazosin—Confusional state—Temozolomide—melanoma	0.000338	0.00155	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000338	0.00154	CcSEcCtD
Doxazosin—Oedema—Temozolomide—melanoma	0.000336	0.00153	CcSEcCtD
Doxazosin—Infection—Temozolomide—melanoma	0.000333	0.00152	CcSEcCtD
Doxazosin—Anorexia—Carmustine—melanoma	0.000331	0.00151	CcSEcCtD
Doxazosin—Epistaxis—Docetaxel—melanoma	0.00033	0.00151	CcSEcCtD
Doxazosin—Thrombocytopenia—Temozolomide—melanoma	0.000329	0.0015	CcSEcCtD
Doxazosin—Feeling abnormal—Bleomycin—melanoma	0.000328	0.0015	CcSEcCtD
Doxazosin—Skin disorder—Temozolomide—melanoma	0.000326	0.00149	CcSEcCtD
Doxazosin—Terazosin—ABCB1—melanoma	0.000326	0.593	CrCbGaD
Doxazosin—Hypotension—Carmustine—melanoma	0.000324	0.00148	CcSEcCtD
Doxazosin—Hyperhidrosis—Temozolomide—melanoma	0.000324	0.00148	CcSEcCtD
Doxazosin—Decreased appetite—Dactinomycin—melanoma	0.000322	0.00147	CcSEcCtD
Doxazosin—Fatigue—Dactinomycin—melanoma	0.00032	0.00146	CcSEcCtD
Doxazosin—Anorexia—Temozolomide—melanoma	0.00032	0.00146	CcSEcCtD
Doxazosin—Pain—Dactinomycin—melanoma	0.000317	0.00145	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Carmustine—melanoma	0.000316	0.00145	CcSEcCtD
Doxazosin—Urticaria—Bleomycin—melanoma	0.000316	0.00144	CcSEcCtD
Doxazosin—Rhinitis—Docetaxel—melanoma	0.000315	0.00144	CcSEcCtD
Doxazosin—Body temperature increased—Bleomycin—melanoma	0.000314	0.00144	CcSEcCtD
Doxazosin—Hepatitis—Docetaxel—melanoma	0.000314	0.00143	CcSEcCtD
Doxazosin—Insomnia—Carmustine—melanoma	0.000314	0.00143	CcSEcCtD
Doxazosin—Hypoaesthesia—Docetaxel—melanoma	0.000312	0.00143	CcSEcCtD
Doxazosin—Paraesthesia—Carmustine—melanoma	0.000312	0.00142	CcSEcCtD
Doxazosin—Pharyngitis—Docetaxel—melanoma	0.000312	0.00142	CcSEcCtD
Doxazosin—Dyspnoea—Carmustine—melanoma	0.00031	0.00141	CcSEcCtD
Doxazosin—Somnolence—Carmustine—melanoma	0.000309	0.00141	CcSEcCtD
Doxazosin—Feeling abnormal—Dactinomycin—melanoma	0.000306	0.0014	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000306	0.0014	CcSEcCtD
Doxazosin—Insomnia—Temozolomide—melanoma	0.000303	0.00139	CcSEcCtD
Doxazosin—Gastrointestinal pain—Dactinomycin—melanoma	0.000303	0.00139	CcSEcCtD
Doxazosin—Visual impairment—Docetaxel—melanoma	0.000303	0.00138	CcSEcCtD
Doxazosin—Decreased appetite—Carmustine—melanoma	0.000302	0.00138	CcSEcCtD
Doxazosin—Paraesthesia—Temozolomide—melanoma	0.000301	0.00138	CcSEcCtD
Doxazosin—Dyspnoea—Temozolomide—melanoma	0.000299	0.00137	CcSEcCtD
Doxazosin—Somnolence—Temozolomide—melanoma	0.000298	0.00136	CcSEcCtD
Doxazosin—Constipation—Carmustine—melanoma	0.000297	0.00136	CcSEcCtD
Doxazosin—Pain—Carmustine—melanoma	0.000297	0.00136	CcSEcCtD
Doxazosin—Dyspepsia—Temozolomide—melanoma	0.000295	0.00135	CcSEcCtD
Doxazosin—Eye disorder—Docetaxel—melanoma	0.000294	0.00134	CcSEcCtD
Doxazosin—Body temperature increased—Dactinomycin—melanoma	0.000293	0.00134	CcSEcCtD
Doxazosin—Abdominal pain—Dactinomycin—melanoma	0.000293	0.00134	CcSEcCtD
Doxazosin—Hypersensitivity—Bleomycin—melanoma	0.000293	0.00134	CcSEcCtD
Doxazosin—Decreased appetite—Temozolomide—melanoma	0.000292	0.00133	CcSEcCtD
Doxazosin—Flushing—Docetaxel—melanoma	0.000291	0.00133	CcSEcCtD
Doxazosin—Fatigue—Temozolomide—melanoma	0.000289	0.00132	CcSEcCtD
Doxazosin—Pain—Temozolomide—melanoma	0.000287	0.00131	CcSEcCtD
Doxazosin—Constipation—Temozolomide—melanoma	0.000287	0.00131	CcSEcCtD
Doxazosin—Feeling abnormal—Carmustine—melanoma	0.000286	0.00131	CcSEcCtD
Doxazosin—Asthenia—Bleomycin—melanoma	0.000285	0.0013	CcSEcCtD
Doxazosin—Gastrointestinal pain—Carmustine—melanoma	0.000284	0.0013	CcSEcCtD
Doxazosin—Chills—Docetaxel—melanoma	0.000282	0.00129	CcSEcCtD
Doxazosin—Pruritus—Bleomycin—melanoma	0.000281	0.00129	CcSEcCtD
Doxazosin—Arrhythmia—Docetaxel—melanoma	0.000281	0.00128	CcSEcCtD
Doxazosin—Alopecia—Docetaxel—melanoma	0.000278	0.00127	CcSEcCtD
Doxazosin—Feeling abnormal—Temozolomide—melanoma	0.000277	0.00126	CcSEcCtD
Doxazosin—Mental disorder—Docetaxel—melanoma	0.000275	0.00126	CcSEcCtD
Doxazosin—Body temperature increased—Carmustine—melanoma	0.000274	0.00125	CcSEcCtD
Doxazosin—Abdominal pain—Carmustine—melanoma	0.000274	0.00125	CcSEcCtD
Doxazosin—Gastrointestinal pain—Temozolomide—melanoma	0.000274	0.00125	CcSEcCtD
Doxazosin—Malnutrition—Docetaxel—melanoma	0.000273	0.00125	CcSEcCtD
Doxazosin—Hypersensitivity—Dactinomycin—melanoma	0.000273	0.00125	CcSEcCtD
Doxazosin—Dysgeusia—Docetaxel—melanoma	0.000268	0.00122	CcSEcCtD
Doxazosin—Urticaria—Temozolomide—melanoma	0.000267	0.00122	CcSEcCtD
Doxazosin—Asthenia—Dactinomycin—melanoma	0.000266	0.00122	CcSEcCtD
Doxazosin—Abdominal pain—Temozolomide—melanoma	0.000265	0.00121	CcSEcCtD
Doxazosin—Body temperature increased—Temozolomide—melanoma	0.000265	0.00121	CcSEcCtD
Doxazosin—Back pain—Docetaxel—melanoma	0.000264	0.00121	CcSEcCtD
Doxazosin—Muscle spasms—Docetaxel—melanoma	0.000263	0.0012	CcSEcCtD
Doxazosin—Hypersensitivity—Carmustine—melanoma	0.000256	0.00117	CcSEcCtD
Doxazosin—Diarrhoea—Dactinomycin—melanoma	0.000254	0.00116	CcSEcCtD
Doxazosin—Vomiting—Bleomycin—melanoma	0.000253	0.00116	CcSEcCtD
Doxazosin—Rash—Bleomycin—melanoma	0.000251	0.00115	CcSEcCtD
Doxazosin—Dermatitis—Bleomycin—melanoma	0.000251	0.00114	CcSEcCtD
Doxazosin—Asthenia—Carmustine—melanoma	0.000249	0.00114	CcSEcCtD
Doxazosin—Hypersensitivity—Temozolomide—melanoma	0.000247	0.00113	CcSEcCtD
Doxazosin—Syncope—Docetaxel—melanoma	0.000245	0.00112	CcSEcCtD
Doxazosin—Leukopenia—Docetaxel—melanoma	0.000245	0.00112	CcSEcCtD
Doxazosin—Palpitations—Docetaxel—melanoma	0.000242	0.0011	CcSEcCtD
Doxazosin—Asthenia—Temozolomide—melanoma	0.000241	0.0011	CcSEcCtD
Doxazosin—Loss of consciousness—Docetaxel—melanoma	0.00024	0.0011	CcSEcCtD
Doxazosin—Cough—Docetaxel—melanoma	0.000239	0.00109	CcSEcCtD
Doxazosin—Diarrhoea—Carmustine—melanoma	0.000238	0.00109	CcSEcCtD
Doxazosin—Pruritus—Temozolomide—melanoma	0.000237	0.00108	CcSEcCtD
Doxazosin—Convulsion—Docetaxel—melanoma	0.000237	0.00108	CcSEcCtD
Doxazosin—Nausea—Bleomycin—melanoma	0.000236	0.00108	CcSEcCtD
Doxazosin—Hypertension—Docetaxel—melanoma	0.000236	0.00108	CcSEcCtD
Doxazosin—Vomiting—Dactinomycin—melanoma	0.000236	0.00108	CcSEcCtD
Doxazosin—Rash—Dactinomycin—melanoma	0.000234	0.00107	CcSEcCtD
Doxazosin—Chest pain—Docetaxel—melanoma	0.000233	0.00106	CcSEcCtD
Doxazosin—Arthralgia—Docetaxel—melanoma	0.000233	0.00106	CcSEcCtD
Doxazosin—Myalgia—Docetaxel—melanoma	0.000233	0.00106	CcSEcCtD
Doxazosin—Dizziness—Carmustine—melanoma	0.00023	0.00105	CcSEcCtD
Doxazosin—Diarrhoea—Temozolomide—melanoma	0.00023	0.00105	CcSEcCtD
Doxazosin—Dry mouth—Docetaxel—melanoma	0.000228	0.00104	CcSEcCtD
Doxazosin—Confusional state—Docetaxel—melanoma	0.000225	0.00103	CcSEcCtD
Doxazosin—Oedema—Docetaxel—melanoma	0.000223	0.00102	CcSEcCtD
Doxazosin—Prazosin—ABCB1—melanoma	0.000223	0.407	CrCbGaD
Doxazosin—Dizziness—Temozolomide—melanoma	0.000222	0.00101	CcSEcCtD
Doxazosin—Infection—Docetaxel—melanoma	0.000222	0.00101	CcSEcCtD
Doxazosin—Vomiting—Carmustine—melanoma	0.000221	0.00101	CcSEcCtD
Doxazosin—Nausea—Dactinomycin—melanoma	0.00022	0.00101	CcSEcCtD
Doxazosin—Shock—Docetaxel—melanoma	0.00022	0.001	CcSEcCtD
Doxazosin—Rash—Carmustine—melanoma	0.000219	0.001	CcSEcCtD
Doxazosin—Dermatitis—Carmustine—melanoma	0.000219	0.000999	CcSEcCtD
Doxazosin—Thrombocytopenia—Docetaxel—melanoma	0.000218	0.000998	CcSEcCtD
Doxazosin—Tachycardia—Docetaxel—melanoma	0.000218	0.000995	CcSEcCtD
Doxazosin—Headache—Carmustine—melanoma	0.000218	0.000994	CcSEcCtD
Doxazosin—Skin disorder—Docetaxel—melanoma	0.000217	0.00099	CcSEcCtD
Doxazosin—Vomiting—Temozolomide—melanoma	0.000213	0.000975	CcSEcCtD
Doxazosin—Anorexia—Docetaxel—melanoma	0.000213	0.000972	CcSEcCtD
Doxazosin—Rash—Temozolomide—melanoma	0.000212	0.000966	CcSEcCtD
Doxazosin—Dermatitis—Temozolomide—melanoma	0.000211	0.000966	CcSEcCtD
Doxazosin—Headache—Temozolomide—melanoma	0.00021	0.00096	CcSEcCtD
Doxazosin—Hypotension—Docetaxel—melanoma	0.000209	0.000952	CcSEcCtD
Doxazosin—Nausea—Carmustine—melanoma	0.000206	0.000942	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000203	0.000929	CcSEcCtD
Doxazosin—Insomnia—Docetaxel—melanoma	0.000202	0.000922	CcSEcCtD
Doxazosin—Paraesthesia—Docetaxel—melanoma	0.0002	0.000915	CcSEcCtD
Doxazosin—Nausea—Temozolomide—melanoma	0.000199	0.00091	CcSEcCtD
Doxazosin—Dyspnoea—Docetaxel—melanoma	0.000199	0.000909	CcSEcCtD
Doxazosin—Somnolence—Docetaxel—melanoma	0.000198	0.000906	CcSEcCtD
Doxazosin—Dyspepsia—Docetaxel—melanoma	0.000196	0.000897	CcSEcCtD
Doxazosin—Decreased appetite—Docetaxel—melanoma	0.000194	0.000886	CcSEcCtD
Doxazosin—Fatigue—Docetaxel—melanoma	0.000192	0.000879	CcSEcCtD
Doxazosin—Pain—Docetaxel—melanoma	0.000191	0.000872	CcSEcCtD
Doxazosin—Constipation—Docetaxel—melanoma	0.000191	0.000872	CcSEcCtD
Doxazosin—Feeling abnormal—Docetaxel—melanoma	0.000184	0.00084	CcSEcCtD
Doxazosin—Gastrointestinal pain—Docetaxel—melanoma	0.000182	0.000833	CcSEcCtD
Doxazosin—Abdominal pain—Docetaxel—melanoma	0.000176	0.000806	CcSEcCtD
Doxazosin—Body temperature increased—Docetaxel—melanoma	0.000176	0.000806	CcSEcCtD
Doxazosin—Hypersensitivity—Docetaxel—melanoma	0.000164	0.000751	CcSEcCtD
Doxazosin—Asthenia—Docetaxel—melanoma	0.00016	0.000731	CcSEcCtD
Doxazosin—Pruritus—Docetaxel—melanoma	0.000158	0.000721	CcSEcCtD
Doxazosin—Diarrhoea—Docetaxel—melanoma	0.000153	0.000697	CcSEcCtD
Doxazosin—Dizziness—Docetaxel—melanoma	0.000148	0.000674	CcSEcCtD
Doxazosin—Vomiting—Docetaxel—melanoma	0.000142	0.000648	CcSEcCtD
Doxazosin—Rash—Docetaxel—melanoma	0.000141	0.000643	CcSEcCtD
Doxazosin—Dermatitis—Docetaxel—melanoma	0.000141	0.000642	CcSEcCtD
Doxazosin—Headache—Docetaxel—melanoma	0.00014	0.000639	CcSEcCtD
Doxazosin—Nausea—Docetaxel—melanoma	0.000133	0.000605	CcSEcCtD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2—melanoma	9.4e-06	0.000106	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—E2F1—melanoma	9.33e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CB—melanoma	9.29e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAP2K1—melanoma	9.25e-06	0.000104	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PDGFRA—melanoma	9.24e-06	0.000104	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CD—melanoma	9.19e-06	0.000104	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2—melanoma	9.18e-06	0.000104	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TERT—melanoma	9.15e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ITGB3—melanoma	9.15e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCA—melanoma	9.15e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—HRAS—melanoma	9.13e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAC1—melanoma	9.13e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PIK3CA—melanoma	9.11e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FN1—melanoma	9.07e-06	0.000102	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.02e-06	0.000102	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—KRAS—melanoma	9e-06	0.000102	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SPP1—melanoma	8.97e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAP2K2—melanoma	8.94e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL8—melanoma	8.93e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOTCH1—melanoma	8.88e-06	0.0001	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGF2—melanoma	8.8e-06	9.94e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HIF1A—melanoma	8.75e-06	9.88e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CD80—melanoma	8.7e-06	9.82e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APC—melanoma	8.68e-06	9.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CG—melanoma	8.68e-06	9.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KIT—melanoma	8.68e-06	9.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—NRAS—melanoma	8.68e-06	9.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGF—melanoma	8.58e-06	9.69e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CG—melanoma	8.57e-06	9.67e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2—melanoma	8.53e-06	9.63e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TERT—melanoma	8.5e-06	9.6e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAC1—melanoma	8.48e-06	9.57e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ABCB1—melanoma	8.42e-06	9.51e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KDR—melanoma	8.37e-06	9.45e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—MAPK3—melanoma	8.31e-06	9.38e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PIK3CA—melanoma	8.27e-06	9.34e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—melanoma	8.27e-06	9.34e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MDM2—melanoma	8.24e-06	9.3e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BRAF—melanoma	8.16e-06	9.21e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HIF1A—melanoma	8.13e-06	9.18e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ERBB2—melanoma	8.12e-06	9.17e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—melanoma	8.06e-06	9.1e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FN1—melanoma	8.06e-06	9.1e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CB—melanoma	8.01e-06	9.05e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—melanoma	7.95e-06	8.97e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—MAPK1—melanoma	7.91e-06	8.93e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—melanoma	7.91e-06	8.93e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOTCH1—melanoma	7.88e-06	8.9e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—melanoma	7.78e-06	8.78e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PRKCA—melanoma	7.75e-06	8.75e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCB1—melanoma	7.74e-06	8.74e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CD80—melanoma	7.72e-06	8.72e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CG—melanoma	7.71e-06	8.7e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KIT—melanoma	7.71e-06	8.7e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APC—melanoma	7.71e-06	8.7e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—NRAS—melanoma	7.71e-06	8.7e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—melanoma	7.7e-06	8.69e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ERCC2—melanoma	7.68e-06	8.68e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAP2K1—melanoma	7.68e-06	8.67e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HRAS—melanoma	7.65e-06	8.64e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CD—melanoma	7.63e-06	8.61e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGF—melanoma	7.62e-06	8.6e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PRKCA—melanoma	7.56e-06	8.54e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CA—melanoma	7.56e-06	8.53e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CD—melanoma	7.53e-06	8.5e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1B—melanoma	7.52e-06	8.49e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ERCC2—melanoma	7.5e-06	8.47e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FN1—melanoma	7.49e-06	8.45e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—KRAS—melanoma	7.47e-06	8.43e-05	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—melanoma	7.44e-06	8.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—melanoma	7.43e-06	8.39e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—MAPK3—melanoma	7.38e-06	8.34e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP3—melanoma	7.37e-06	8.32e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—melanoma	7.36e-06	8.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOTCH1—melanoma	7.32e-06	8.27e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—melanoma	7.32e-06	8.27e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGF2—melanoma	7.31e-06	8.25e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BRAF—melanoma	7.25e-06	8.18e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CD80—melanoma	7.18e-06	8.1e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCND1—melanoma	7.17e-06	8.1e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KIT—melanoma	7.16e-06	8.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CG—melanoma	7.16e-06	8.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APC—melanoma	7.16e-06	8.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—NRAS—melanoma	7.16e-06	8.09e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PRKCA—melanoma	7.13e-06	8.05e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CTNNB1—melanoma	7.1e-06	8.02e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGF—melanoma	7.08e-06	7.99e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ERCC2—melanoma	7.07e-06	7.98e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—melanoma	7.06e-06	7.97e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—MAPK1—melanoma	7.03e-06	7.93e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—melanoma	7.02e-06	7.93e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—melanoma	6.96e-06	7.86e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1A—melanoma	6.94e-06	7.84e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTEN—melanoma	6.92e-06	7.82e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NFKB1—melanoma	6.89e-06	7.78e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CA—melanoma	6.86e-06	7.75e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MAPK3—melanoma	6.86e-06	7.75e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MDM2—melanoma	6.84e-06	7.72e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAP2K1—melanoma	6.82e-06	7.7e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CD—melanoma	6.78e-06	7.65e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—melanoma	6.76e-06	7.63e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ERBB2—melanoma	6.74e-06	7.61e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BRAF—melanoma	6.73e-06	7.6e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	6.71e-06	7.58e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CB—melanoma	6.65e-06	7.51e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—KRAS—melanoma	6.64e-06	7.49e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CB—melanoma	6.56e-06	7.41e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—melanoma	6.56e-06	7.41e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MAPK1—melanoma	6.53e-06	7.37e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—melanoma	6.53e-06	7.37e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—melanoma	6.5e-06	7.34e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGF2—melanoma	6.49e-06	7.33e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—melanoma	6.39e-06	7.22e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.37e-06	7.19e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HRAS—melanoma	6.35e-06	7.17e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAP2K1—melanoma	6.34e-06	7.16e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CD—melanoma	6.3e-06	7.11e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—melanoma	6.25e-06	7.06e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1B—melanoma	6.24e-06	7.05e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	6.24e-06	7.04e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—melanoma	6.19e-06	6.99e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NRAS—melanoma	6.18e-06	6.97e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—melanoma	6.17e-06	6.97e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—KRAS—melanoma	6.17e-06	6.96e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP3—melanoma	6.12e-06	6.91e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—melanoma	6.11e-06	6.9e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	6.1e-06	6.88e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—melanoma	6.08e-06	6.86e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MDM2—melanoma	6.07e-06	6.86e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CG—melanoma	6.07e-06	6.85e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGF2—melanoma	6.03e-06	6.81e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ERBB2—melanoma	5.99e-06	6.76e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCND1—melanoma	5.95e-06	6.72e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CG—melanoma	5.92e-06	6.69e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK3—melanoma	5.92e-06	6.68e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CB—melanoma	5.91e-06	6.67e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CTNNB1—melanoma	5.9e-06	6.66e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—melanoma	5.86e-06	6.61e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—melanoma	5.78e-06	6.53e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1A—melanoma	5.76e-06	6.5e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—melanoma	5.75e-06	6.5e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTEN—melanoma	5.75e-06	6.49e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NFKB1—melanoma	5.72e-06	6.46e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—melanoma	5.72e-06	6.46e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—melanoma	5.68e-06	6.41e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTEN—melanoma	5.67e-06	6.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	5.66e-06	6.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MDM2—melanoma	5.64e-06	6.37e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HRAS—melanoma	5.64e-06	6.37e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK1—melanoma	5.63e-06	6.36e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—melanoma	5.63e-06	6.35e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—melanoma	5.61e-06	6.33e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CG—melanoma	5.58e-06	6.3e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ERBB2—melanoma	5.56e-06	6.28e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1B—melanoma	5.54e-06	6.26e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CB—melanoma	5.49e-06	6.2e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—melanoma	5.48e-06	6.19e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP3—melanoma	5.43e-06	6.13e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—melanoma	5.43e-06	6.13e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—melanoma	5.4e-06	6.09e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—melanoma	5.39e-06	6.08e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CD—melanoma	5.34e-06	6.02e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KRAS—melanoma	5.32e-06	6e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCND1—melanoma	5.29e-06	5.97e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—melanoma	5.27e-06	5.96e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—melanoma	5.27e-06	5.95e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HRAS—melanoma	5.24e-06	5.92e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CTNNB1—melanoma	5.24e-06	5.91e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CD—melanoma	5.21e-06	5.88e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—melanoma	5.19e-06	5.86e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1B—melanoma	5.15e-06	5.82e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—melanoma	5.14e-06	5.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—melanoma	5.14e-06	5.8e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—melanoma	5.13e-06	5.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NRAS—melanoma	5.13e-06	5.79e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1A—melanoma	5.12e-06	5.78e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTEN—melanoma	5.1e-06	5.76e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—melanoma	5.1e-06	5.75e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NFKB1—melanoma	5.08e-06	5.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP3—melanoma	5.05e-06	5.7e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—melanoma	5.04e-06	5.69e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—melanoma	5.02e-06	5.66e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—melanoma	4.98e-06	5.62e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCND1—melanoma	4.91e-06	5.55e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK3—melanoma	4.91e-06	5.54e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CD—melanoma	4.91e-06	5.54e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CA—melanoma	4.88e-06	5.52e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CTNNB1—melanoma	4.87e-06	5.49e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—melanoma	4.84e-06	5.47e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—melanoma	4.78e-06	5.39e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—melanoma	4.77e-06	5.39e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1A—melanoma	4.75e-06	5.37e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTEN—melanoma	4.74e-06	5.36e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—melanoma	4.73e-06	5.34e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NFKB1—melanoma	4.72e-06	5.33e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK1—melanoma	4.67e-06	5.28e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—melanoma	4.67e-06	5.27e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CB—melanoma	4.65e-06	5.25e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—melanoma	4.63e-06	5.22e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—melanoma	4.61e-06	5.21e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—melanoma	4.61e-06	5.2e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—melanoma	4.57e-06	5.15e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NRAS—melanoma	4.55e-06	5.14e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CB—melanoma	4.54e-06	5.12e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HRAS—melanoma	4.52e-06	5.1e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—melanoma	4.5e-06	5.08e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KRAS—melanoma	4.41e-06	4.98e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK3—melanoma	4.36e-06	4.92e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—melanoma	4.33e-06	4.88e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—melanoma	4.28e-06	4.84e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CB—melanoma	4.28e-06	4.83e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—melanoma	4.24e-06	4.79e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—melanoma	4.24e-06	4.79e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—melanoma	4.24e-06	4.79e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NRAS—melanoma	4.23e-06	4.78e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK1—melanoma	4.15e-06	4.69e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—melanoma	4.15e-06	4.68e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CA—melanoma	4.05e-06	4.58e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK3—melanoma	4.05e-06	4.58e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTEN—melanoma	4.02e-06	4.54e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CA—melanoma	4e-06	4.52e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—melanoma	3.99e-06	4.51e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—melanoma	3.94e-06	4.45e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTEN—melanoma	3.92e-06	4.43e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—melanoma	3.92e-06	4.43e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KRAS—melanoma	3.92e-06	4.43e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK1—melanoma	3.86e-06	4.35e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—melanoma	3.86e-06	4.35e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HRAS—melanoma	3.75e-06	4.24e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTEN—melanoma	3.7e-06	4.17e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KRAS—melanoma	3.64e-06	4.11e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CA—melanoma	3.6e-06	4.07e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—melanoma	3.59e-06	4.05e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—melanoma	3.48e-06	3.93e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CA—melanoma	3.35e-06	3.78e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HRAS—melanoma	3.33e-06	3.76e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—melanoma	3.31e-06	3.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—melanoma	3.27e-06	3.69e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—melanoma	3.24e-06	3.65e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—melanoma	3.19e-06	3.6e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HRAS—melanoma	3.1e-06	3.5e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—melanoma	2.96e-06	3.35e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—melanoma	2.94e-06	3.32e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CA—melanoma	2.83e-06	3.2e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CA—melanoma	2.77e-06	3.12e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—melanoma	2.73e-06	3.09e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CA—melanoma	2.61e-06	2.94e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—melanoma	2.32e-06	2.61e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—melanoma	2.26e-06	2.55e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—melanoma	2.13e-06	2.41e-05	CbGpPWpGaD
